Saturday, November 26, 2005


Peregrine Pharmaceuticals Names Leading Viral Experts to Its Scientific Resource Board (Hep C Chronic Fatigue)


Peregrine Pharmaceuticals Names Leading Viral Experts to Its Scientific Resource Board
PR Newswire - Phase I clinical trial forthe treatment of chronic hepatitis C infection (HCV) and is being studiedpreclinically for use

Breastfeeding does not raise the risk of mother-to-child transmission of hepatitis C virus
News-Medical.Net - or discouraged from breastfeeding on the basis of hepatitis C infection alone,' said Pier-Angelo Tovo, MD, the lead